Vitamin D, an inflammatory activity marker for spondyloarthritis?

What Was Tested

This observational study looks at Vitamin D, K2, Magnesium and Zinc.

The aim of this study is to determine the association between 25-hydroxyvitamin D deficiency and level of disease activity in patients suffering from spondyloarthritis.

Why It Was Studied

In this study, a relationship between low levels of vitamin D and other markers of inflammation is observed in patients with spondyloarthritis.

Therefore, insufficient levels of vitamin D could be used as a marker of inflammation, so they would help to have a better follow-up of the patient.

Who Took Part

A retrospective review of patients with spondyloarthritis under treatment at the Rheumatology Department of Hospital General Universitario de Ciudad Real between September 2016 and September 2018 is under consideration.

How the Study Was Run

This study is an observational, descriptive and transversal study.

What Was Measured

In this study, a relationship between low levels of vitamin D and other markers of inflammation is observed in patients with spondyloarthritis.

Therefore, insufficient levels of vitamin D could be used as a marker of inflammation, so they would help to have a better follow-up of the patient.

Topics PubMed links to this paper include Spondylarthritis, Vitamin D, Vitamin D Deficiency and Vitamins.

The authors tagged it with the keywords Bone mineral density, Inflammatory biomarkers, Osteoporosis and Spondyloarthritis.

What This Means in Plain Language

This is an observational study of Vitamin D, K2, Magnesium and Zinc.

Its findings take up roughly 7 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.

The publication is from 2020 (Archives of osteoporosis), a journal based in England.

More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.